DOWNERS GROVE, Ill., Feb. 12, 2018 /PRNewswire/ -- Univar Inc. (NYSE: UNVR) ("Univar"), a global chemical and ingredient distributor and provider of value-added services, together with ABITEC Corp. have recently reached a distribution agreement for the CAPMUL®, CAPTEX®, CAPROL®, ACCONON®, STEROTEX®, NUTRI SPERSE®, HYRDO-KOTE® and PURECO® product lines in Canada, effective February 1, 2018.
Owned by Associated British Foods (ABF), ABITEC Corporation is a division of ABF Ingredients. As a world leader in the development and production of lipids and specialty ingredients, ABITEC creates its products primarily from renewable sources. In the pharmaceutical market, these products are used for a wide-array of applications including: solubilization, emulsification and lubrication to improve drug delivery and enhance bioavailability. In the nutraceutical market, these products are used in a number of health applications including sports nutrition and performance, as well as weight management.
This agreement expands Univar's specialty portfolio to provide customers with important and relevant solutions that will help to overcome some of the most intricate formulating issues facing the pharmaceutical and nutraceutical industries today. Customers in these markets will benefit from the combined value of ABITEC's specialty lipid product portfolio and Univar's safety, supply chain, and formulation expertise.
"We are excited to collaborate with ABITEC, which further enhances our portfolio of highly-functional ingredients for the pharmaceutical and nutraceutical industries, both of which, we have identified as strategic growth industries for Univar," said Willy St. Cyr, Univar's vice president of product and industry development. He further added, "ABITEC's superior product portfolio coupled with Univar's technical expertise will help provide customers next generation solutions to today's most complex formulation challenges. ABITEC's heavy reliance on renewable resources also aligns well with industry megatrends and Univar's focus on sustainability."
Dr. John Tillotson, technical business director at ABITEC, commented, "ABITEC is pleased to embark on this partnership with Univar to market and distribute ABITEC's highly-functional line of pharmaceutical and nutraceutical excipients throughout Canada. Univar has a long-standing reputation for their strong capabilities in the technical distribution of highly-functional products in the market, and this relationship offers strong support for ABITEC's business and growth in Canada."
Article Source: univar.com